These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
þ
|
No fee required.
|
||
|
|
|
|
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
||
|
|
|
|
|
|
|
(1
|
)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
|
(2
|
)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
|
(3
|
)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
|
(4
|
)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
(5
|
)
|
Total fee paid:
|
|
|
|
|
|
|
¨
|
Fee paid previously with preliminary materials:
|
||
|
|
|
|
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
|
||
|
|
|
|
|
|
|
(1
|
)
|
Amount previously paid:
|
|
|
|
|
|
|
|
(2
|
)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
(3
|
)
|
Filing Party:
|
|
|
|
|
|
|
|
(4
|
)
|
Date Filed:
|
|
Sincerely yours,
|
|
|
Victor J. Coleman
|
|
Chief Executive Officer, President and Chairman of the Board of Directors
|
|
|
|
|
|
|
|
NOTICE OF 2014 ANNUAL MEETING OF STOCKHOLDERS
|
||||
|
|
|
|
|
|
|
(1)
|
The election of eight directors, each to serve until the next annual meeting of our stockholders and until his successor is duly elected and qualifies;
|
|
(2)
|
The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
|
|
(3)
|
The advisory approval of the Company’s executive compensation for the fiscal year ended December 31, 2013, as more fully disclosed in the accompanying proxy statement; and
|
|
(4)
|
Any other business properly introduced at the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
|
By Order of the Board of Directors
|
|
|
Kay L. Tidwell
|
|
Executive Vice President, General Counsel and Secretary
|
|
|
|
Page
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards in 2013 Table
|
|
|
|
Outstanding Equity Awards at 2013 Fiscal Year-End
|
|
|
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
PROXY STATEMENT
|
||||
|
|
|
|
|
|
|
(1)
|
the election of eight directors (each to serve until the next annual meeting of our stockholders and until his successor is duly elected and qualifies);
|
|
(2)
|
the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
|
|
(3)
|
the advisory approval of the Company’s executive compensation for the fiscal year ended December 31, 2013, as more fully described in this Proxy Statement; and
|
|
(4)
|
any other business properly introduced at the Annual Meeting or any adjournment or postponement thereof.
|
|
•
|
for
the election of each nominee named in this Proxy Statement (see Proposal No. 1);
|
|
•
|
for
ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014 (see Proposal No. 2); and
|
|
•
|
for
the advisory approval of the Company’s executive compensation (see Proposal No. 3).
|
|
•
|
With respect to Proposal No. 1 (Election of Directors), your broker, bank or other nominee is not entitled to vote your shares if no instructions are received from you. Broker non-votes, if any, will have no effect on the election of directors.
|
|
•
|
With respect to Proposal No. 2 (Ratification of Independent Registered Public Accounting Firm), your broker is entitled to vote your shares if no instructions are received from you.
|
|
•
|
With respect to Proposal No. 3 (Advisory Approval of Executive Compensation), your broker, bank or other nominee is not entitled to vote your shares if no instructions are received from you. Broker non-votes, if any, will have no effect on the result of the vote on this proposal.
|
|
•
|
If you received a paper copy of the proxy materials by mail, sign and mail the proxy card in the enclosed return envelope;
|
|
•
|
Call 1-800-652-VOTE (8683); or
|
|
•
|
Log on to the Internet at
www.investorvote.com/HPP
and follow the instructions at that site. The Web site address for authorizing a proxy by Internet is also provided on your notice at the Annual Meeting.
|
|
•
|
Filing written notice of revocation before our Annual Meeting with our Executive Vice President, General Counsel and Secretary, Kay L. Tidwell, at the address shown on the front of this Proxy Statement;
|
|
•
|
Signing a proxy bearing a later date; or
|
|
•
|
Voting in person at the Annual Meeting.
|
|
Name
|
|
Age
|
|
Position
|
|
|
Victor J. Coleman
|
|
52
|
|
|
Director; Chief Executive Officer; President; Chairman of the Board
|
|
Theodore R. Antenucci†
|
|
49
|
|
|
Director; Audit Committee member, Governance Committee and Investment Committee member
|
|
Richard B. Fried
|
|
45
|
|
|
Director
|
|
Jonathan M. Glaser†
|
|
51
|
|
|
Director; Audit Committee member, Compensation Committee Chairperson and Investment Committee member
|
|
Mark D. Linehan†
|
|
51
|
|
|
Director; Audit Committee Chairperson, Compensation Committee member and Investment Committee member
|
|
Robert M. Moran, Jr.†
|
|
51
|
|
|
Director; Governance Committee Chairperson and Investment Committee member
|
|
Barry A. Porter†
|
|
56
|
|
|
Director; Compensation Committee member and Governance Committee member
|
|
Patrick Whitesell†
|
|
49
|
|
|
Director
|
|
Name
(1)
|
|
Fee Earned in Cash ($)
(2)
|
|
Stock Awards ($)
(3)
|
Total ($)
|
|||
|
Theodore R. Antenucci
|
|
71,500
|
|
|
75,000
|
|
146,500
|
|
|
|
|
|
|
|
|
|||
|
Jonathan M. Glaser
|
|
77,500
(4)
|
|
|
75,000
|
|
152,500
|
|
|
|
|
|
|
|
|
|||
|
Richard B. Fried
|
|
60,000
|
|
|
75,000
|
|
135,000
|
|
|
|
|
|
|
|
|
|||
|
Mark D. Linehan
|
|
80,000
|
|
|
75,000
|
|
155,000
|
|
|
|
|
|
|
|
|
|||
|
Robert M. Moran, Jr.
|
|
67,500
|
|
|
75,000
|
|
142,500
|
|
|
|
|
|
|
|
|
|||
|
Barry A. Porter
|
|
69,000
(4)
|
|
|
75,000
|
|
144,000
|
|
|
|
|
|
|
|
|
|||
|
Patrick Whitesell
|
|
60,000
|
|
|
75,000
|
|
135,000
|
|
|
(1)
|
Mr. Coleman, our Chief Executive Officer, and Mr. Stern, our former President and director, are not included in this table as they were employees of the Company in 2013 and did not receive compensation for their services as directors. All compensation paid to Messrs. Coleman and Stern for the services they provided to us in 2013 is reflected in the Summary Compensation Table.
|
|
(2)
|
Reflects annual base and, if applicable, committee retainer fees earned in 2013.
|
|
(3)
|
Each non-employee director serving on our Board on the date of our annual stockholders’ meeting in 2013 received a grant of restricted stock valued at $75,000 on the grant date, with the number of shares determined by dividing $75,000 by the closing price of our common stock on the grant date. Each restricted stock award will vest, and the restrictions thereon will lapse, in three equal annual installments on each of the first three anniversaries of May 17, 2013, subject to continued service with us through the applicable vesting dates. Amounts reflect the full grant-date fair value of restricted stock awards granted with respect to services performed in 2013 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all restricted stock awards made to directors in Notes 2 and 10 to the consolidated financial statements contained in our Annual Report of Form 10-K, filed on March 3, 2014. As of December 31, 2013, Messrs. Antenucci, Glaser, Fried, Linehan, Moran, Porter and Whitesell held 6,309, 6,309, 6,309, 6,309, 6,309, 6,309 and 5,969 shares, respectively, of our restricted common stock.
|
|
(4)
|
Pursuant to our Director Stock Plan, Messrs. Glaser and Porter elected to receive, on a non-deferred basis, all of their non-committee cash retainer fees earned in 2013 in the form of fully-vested shares of our common stock having an equal value to the amount otherwise payable in cash.
|
|
•
|
our Board of Directors is not staggered, with each of our directors subject to re-election annually;
|
|
•
|
of the eight persons who serve on our Board of Directors, our Board of Directors has determined that 6, or 75%, of our directors satisfy the listing standards for independence of the NYSE and Rule 10A-3 under the Securities Exchange Act of 1934, as amended, or the Exchange Act;
|
|
•
|
at least one of our directors qualifies as an “audit committee financial expert” as defined by the SEC;
|
|
•
|
we have opted out of the control share acquisition statute in the Maryland General Corporation Law, or the MGCL, and have exempted from the business combination provisions of the MGCL any business combination that is first approved by our Board of Directors, including a majority of our disinterested directors; and
|
|
•
|
we do not have a stockholder rights plan.
|
|
•
|
our accounting and financial reporting processes;
|
|
•
|
the integrity of our consolidated financial statements and financial reporting process;
|
|
•
|
our systems of disclosure controls and procedures and internal control over financial reporting;
|
|
•
|
our compliance with financial, legal and regulatory requirements;
|
|
•
|
the evaluation of the qualifications, independence and performance of our independent registered public accounting firm;
|
|
•
|
the performance of our internal audit function; and
|
|
•
|
our overall risk profile.
|
|
•
|
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration of our Chief Executive Officer based on such evaluation;
|
|
•
|
reviewing and approving the compensation of all of our other officers;
|
|
•
|
reviewing our executive compensation policies and plans;
|
|
•
|
implementing and administering our incentive compensation equity-based remuneration plans;
|
|
•
|
assisting management in complying with our proxy statement and annual report disclosure requirements;
|
|
•
|
producing a report on executive compensation to be included in our annual proxy statement;
|
|
•
|
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors; and
|
|
•
|
consistent with new listing exchange rules, considering the independence of its compensation advisers.
|
|
•
|
identifying and recommending to the full Board of Directors qualified candidates for election as directors to fill vacancies on the Board and recommending nominees for election as directors at the annual meeting of stockholders;
|
|
•
|
developing and recommending to the Board of Directors corporate governance guidelines and implementing and monitoring such guidelines;
|
|
•
|
reviewing and making recommendations on matters involving the general operation of the Board of Directors, including Board size and composition, and committee composition and structure;
|
|
•
|
recommending to the Board of Directors nominees for each committee of the Board of Directors;
|
|
•
|
annually facilitating the assessment of the Board of Directors’ performance as a whole and of the individual directors, as required by applicable law, regulations and the NYSE corporate governance listing standards; and
|
|
•
|
overseeing the Board of Directors’ evaluation of the performance of management.
|
|
•
|
honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
|
|
•
|
full, fair, accurate, timely and understandable disclosure in our SEC reports and other public communications;
|
|
•
|
compliance with applicable governmental laws, rules and regulations;
|
|
•
|
prompt internal reporting of violations of the code to appropriate persons identified in the code; and
|
|
•
|
accountability for adherence to the code of business conduct and ethics.
|
|
•
|
Mr. Linehan received a B.A. degree in Business Economics from the University of California, Santa Barbara.
|
|
•
|
Mr. Linehan is a Certified Public Accountant.
|
|
•
|
Mr. Linehan was previously employed by Kenneth Leventhal & Co. (now Ernst & Young LLP), a Los Angeles-based public accounting firm.
|
|
•
|
Mr. Linehan has served as President and Chief Executive Officer of Wynmark Company since he founded the company in 1993.
|
|
|
Fiscal Year Ended December 31,
|
||||||||
|
|
|
|
2013
|
|
|
2012
|
|
||
|
Audit Fees
|
|
|
$
|
1,060
|
|
|
$
|
904
|
|
|
Audit-Related Fees
|
|
|
$
|
2
|
|
|
$
|
2
|
|
|
Tax Fees
|
|
|
$
|
502
|
|
|
$
|
439
|
|
|
All Other Fees
|
|
|
-
|
|
|
-
|
|
||
|
|
|
|
|
|
|
||||
|
Total Fees
|
|
|
$
|
1,564
|
|
|
$
|
1,345
|
|
|
•
|
Annual Equity Awards.
We grant annual restricted stock awards to ensure alignment with stockholders by enabling our executives to establish a meaningful equity stake in the Company upon grant, determined based on an assessment of the Company’s overall performance for the applicable year.
|
|
•
|
Multi-Year Performance Equity Awards.
We grant multi-year performance awards to ensure alignment with stockholders over a multi-year period, which will only be earned by our executives if the Company achieves certain defined absolute and relative total shareholder return targets over the applicable three-year performance period.
|
|
Name
|
|
Age
|
|
Position
|
|
|
Victor J. Coleman*
|
|
52
|
|
|
Chief Executive Officer and Chairman of the Board of Directors
|
|
Mark T. Lammas*
|
|
47
|
|
|
Chief Financial Officer and Treasurer
|
|
Christopher Barton*
|
|
49
|
|
|
Executive Vice President, Operations and Development
|
|
Dale Shimoda*
|
|
46
|
|
|
Executive Vice President, Finance
|
|
Kay L. Tidwell
|
|
36
|
|
|
Executive Vice President, General Counsel and Secretary
|
|
Harout Diramerian
|
|
39
|
|
|
Chief Accounting Officer
|
|
Alexander Vouvalides*
|
|
35
|
|
|
Chief Investment Officer
|
|
Drew Gordon
|
|
47
|
|
|
Senior Vice President, Pacific Northwest
|
|
•
|
Achieved total shareholder return performance for the three-year period at the 100
th
percentile of the performance-based executive compensation peer group and 70
th
percentile of the size-based peer group (each as defined below);
|
|
•
|
Successfully beat consensus FFO estimates for each quarter of 2013;
|
|
•
|
Successfully sourced and executed acquisitions with a gross purchase price of nearly $550.0 million, aggregating more than one million square feet of office space in the Company’s target markets;
|
|
•
|
Maintained a flexible capital structure demonstrated through the (i) the raising of approximately $190 million of equity capital and (ii) successful assumption or origination of nearly $550.0 million of corporate and project financing; and
|
|
•
|
Executed 58 new and renewal leases for more than 750,000 square feet resulting in a stabilized office portfolio occupancy rate of 95.4% as of the end of 2013, up from 93.5% occupancy rate as of the end of 2012.
|
|
•
|
Approved a 6.5% base salary increase for Mr. Vouvalides in 2014 designed to better align his base salary with his respective peer group; other named executive officers did not receive a base salary increase for 2014, as the
|
|
•
|
In light of the strong year-over-year performance, as summarized under “2013 Business Highlights” above, our Compensation Committee awarded annual cash bonuses to our named executive officers that were closely aligned to market and representative of short- and long-term performance and value creation for our stockholders.
|
|
•
|
Awarded annual equity grants on December 29, 2013 determined based on an evaluation of our overall 2013 performance. Equity grants included a two-year no-sell provision upon vesting to ensure our named executive officers are in shoulder-to-shoulder alignment with shareholders.
|
|
•
|
Implemented, on January 1, 2014, the 2014 Outperformance Program that will allow our executives to earn additional equity awards to the extent that the Company exceeds certain defined absolute and relative total shareholder return targets over a prospective three-year performance period.
|
|
Compensation Element
|
Primary Objective
|
|
Base salary
|
To recognize ongoing performance of job responsibilities and to provide a necessary tool in attracting and retaining executives.
|
|
Annual performance-based cash compensation (bonuses)
|
To emphasize short-term corporate objectives and individual contributions to the achievement of those objectives.
|
|
Long-term equity incentive compensation
|
To emphasize long-term performance objectives, align the interests of our executives with shareholder interests, encourage the maximization of shareholder value and retain key executives.
|
|
Severance and change in control benefits
|
To encourage the continued attention and dedication of our executives and provide reasonable individual security to enable our executives to focus on our best interests, particularly when considering strategic alternatives.
|
|
Retirement savings (401(k)) plan
|
To provide retirement savings in a tax-efficient manner.
|
|
Health and welfare benefits
|
To provide a basic level of protection from health, dental, life and disability risks.
|
|
•
|
To attract, retain and motivate a high-quality executive management team capable of creating long-term stockholder value;
|
|
•
|
To provide compensation opportunities that are competitive with the prevailing market, are rooted in a pay-for-performance philosophy, and create a strong alignment of management and stockholder interests; and
|
|
•
|
To achieve an appropriate balance between risk and reward in our compensation programs that does not incentivize unnecessary or excessive risk taking.
|
|
•
|
base salary;
|
|
•
|
annual discretionary performance-based cash bonuses;
|
|
•
|
equity incentive compensation grants and multi-year outperformance programs;
|
|
•
|
certain severance and change in control benefits; and
|
|
•
|
retirement, health and welfare benefits and certain limited perquisites and other personal benefits.
|
|
Alexandria Real Estate Equities, Inc.
|
Digital Realty Trust, Inc.
|
Kilroy Realty Corporation
|
Piedmont Office Realty Trust, Inc.
|
|
BioMed Realty Trust, Inc.
|
Douglas Emmett, Inc.
|
Lexington Realty Trust
|
PS Business Parks, Inc.
|
|
Brandywine Realty Trust
|
EPR Properties
|
Mack-Cali Realty Corporation
|
Realty Income Corporation
|
|
Corporate Office Properties Trust
|
Highwoods Properties, Inc.
|
Parkway Properties, Inc.
|
Washington Real Estate Investment Trust
|
|
Acadia Realty Trust
|
CubeSmart
|
Hersha Hospitality Trust
|
Retail Opportunity Investments Corp.
|
|
Arlington Asset Investment Corp.
|
FelCor Lodging Trust Incorporated
|
Lexington Realty Trust
|
Strategic Hotels & Resorts
|
|
Ashford Hospitality Trust, Inc.
|
First Industrial Realty Trust, Inc.
|
LTC Properties, Inc.
|
Sun Communities, Inc.
|
|
Associated Estates Realty Corporation
|
First Potomac Realty Trust
|
National HealthCare Corporation
|
Sunstone Hotel Investors, Inc.
|
|
Cedar Realty Trust, Inc.
|
Glimcher Realty Trust
|
Pebblebrook Hotel Trust
|
Urstadt Biddle Properties Inc.
|
|
Cousins Properties
Incorporated
|
Gramercy Capital Corp.
|
Pennsylvania Real Estate Investment Trust
|
|
|
•
|
Achieved total shareholder return performance for the three-year period at the 100
th
percentile of the performance-based executive compensation peer group and 70
th
percentile of the size-based peer group (each as defined below);
|
|
•
|
Successfully beat consensus FFO estimates for each quarter of 2013;
|
|
•
|
Successfully sourced and executed acquisitions with a gross purchase price of nearly $550.0 million and consisting of seven properties aggregating more than 1 million square feet of office space in the Company’s target markets and planned expansion into the Pacific Northwest;
|
|
•
|
Successfully disposed of 330,000 square-foot office property and completed 1031 tax-free exchange of proceeds;
|
|
•
|
Maintained a flexible capital structure demonstrated through the (i) the raising of approximately $190 million of equity capital and (ii) successful assumption or origination of nearly $550.0 million of corporate and project financing, including the replacement of its $200.0 million secured revolving credit facility with a $250.0 million unsecured revolving credit facility on improved terms;
|
|
•
|
Executed 58 new and renewal leases for more than 750,000 square feet; and
|
|
•
|
Demonstrated sound operating results that has led to a current stabilized office portfolio occupancy rate of 95.4% as of the end of 2013, nearly 200 basis points higher than the 93.5% occupancy rate as of the end of 2012.
|
|
Executive
|
|
2013 Bonus
|
|
2013 Bonus as a Percentage of Base Salary
|
|||
|
Victor J. Coleman
|
|
$
|
1,200,000
|
|
|
200
|
%
|
|
Howard S. Stern
|
|
$
|
450,000
|
|
|
100
|
%
|
|
Mark T. Lammas
|
|
$
|
450,000
|
|
|
100
|
%
|
|
Christopher Barton
|
|
$
|
400,000
|
|
|
107
|
%
|
|
Alexander Vouvalides
|
|
$
|
375,000
|
|
|
121
|
%
|
|
Named Executive Officer
|
|
2013 OPP Award Bonus Percentage
|
|
Maximum Potential Dollar-Denominated Award under 2013 OPP
|
|||
|
Victor J. Coleman
|
|
22.73
|
%
|
|
|
$2,500,300
|
|
|
Mark T. Lammas
|
|
15
|
%
|
|
|
$1,650,000
|
|
|
Christopher Barton
|
|
10
|
%
|
|
|
$1,100,000
|
|
|
Alexander Vouvalides
|
|
7.5
|
%
|
|
|
$825,000
|
|
|
Name and Principal Position
|
|
Year
|
|
Salary ($)
|
|
Bonus ($)
(1)
|
|
Stock
Awards ($)
(2)
|
|
All Other Compensation
|
|
Total ($)
|
|||||
|
Victor J. Coleman
|
|
2013
|
|
600,000
|
|
|
1,200,000
|
|
|
2,428,792
|
|
|
594
|
|
|
4,229,386
|
|
|
Chief Executive Officer
|
|
2012
|
|
500,000
|
|
|
1,000,000
|
|
|
2,445,310
(3)
|
|
|
598
|
|
|
3,945,908
|
|
|
|
|
2011
|
|
500,000
|
|
|
1,000,000
|
|
|
1,500,001
|
|
|
23,891
|
|
|
3,023,892
|
|
|
Howard S. Stern
|
|
2013
|
|
450,000
|
|
|
450,000
|
|
|
621,000
|
|
|
594
|
|
|
1,521,594
|
|
|
President
|
|
2012
|
|
400,000
|
|
|
575,000
|
|
|
1,161,120
(3)
|
|
|
598
|
|
|
2,136,718
|
|
|
|
|
2011
|
|
400,000
|
|
|
575,000
|
|
|
674,999
|
|
|
643
|
|
|
1,650,642
|
|
|
Mark T. Lammas
|
|
2013
|
|
450,000
|
|
|
450,000
|
|
|
1,386,135
|
|
|
594
|
|
|
2,286,729
|
|
|
Chief Financial Officer
|
|
2012
|
|
300,000
|
|
|
450,000
|
|
|
1,161,120
(3)
|
|
|
598
|
|
|
1,911,718
|
|
|
|
|
2011
|
|
300,000
|
|
|
425,000
|
|
|
424,999
|
|
|
643
|
|
|
1,150,642
|
|
|
Christopher Barton
|
|
2013
|
|
375,000
|
|
|
400,000
|
|
|
690,310
|
|
|
594
|
|
|
1,465,904
|
|
|
Executive Vice President, Operations and Development
|
|
2012
|
|
300,000
|
|
|
400,000
|
|
|
625,304
(3)
|
|
|
598
|
|
|
1,325,902
|
|
|
|
|
2011
|
|
300,000
|
|
|
300,000
|
|
|
250,000
|
|
|
643
|
|
|
850,643
|
|
|
Alexander Vouvalides
(4)
|
|
2013
|
|
310,000
|
|
|
375,000
|
|
|
714,327
|
|
|
594
|
|
|
1,399,921
|
|
|
Senior Vice President, Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
(1)
|
Amounts represent discretionary bonuses paid to our named executive officers in respect of services provided during the applicable fiscal year.
|
|
(2)
|
Amounts reflect the full grant-date fair value of restricted stock awards and OPP awards granted in the applicable year, each computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. The grant-date fair values relating to 2013 restricted stock awards are $1,487,770, $765,135, $276,310 and $403,827 for Messrs. Coleman, Lammas, Barton and Vouvalides, respectively. The 2013 OPP award amounts are $941,022, $621,000, $621,000, $414,000 and $310,500 for Messrs. Coleman, Stern, Lammas, Barton and Vouvalides, respectively. We provide information regarding the assumptions used to calculate the value of all restricted stock awards and awards under the 2013 OPP made to executive officers in Notes 2 and 10 to the consolidated financial statements contained in our Annual Report on Form 10-K, filed March 3, 2014. There can be no assurance that awards will vest (if an award does not vest, no value will be realized by the individual). The single measure that determines the number of shares issued under our 2013 OPP to a named executive officer is our TSR compared with an absolute threshold and the SNL Equity REIT Index, computed over the applicable performance period as described in more detail in “
Elements of Executive Officer Compensation-Outperformance Program
” above. The awards under the 2013 OPP are treated as market condition shares as defined under ASC Topic 718, and as a result, the grant date values will not differ from the fair values presented in the table above.
|
|
(3)
|
Amounts reflect the full grant-date fair value of restricted stock awards granted in 2012 and awards under the 2012 OPP, each computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. The grant-date fair values relating to 2012 restricted stock awards are $1,572,810, $637,620, $637,620 and $276,304 for Messrs. Coleman, Stern, Lammas and Barton, respectively. The 2012 OPP award amounts are $872,500, $523,500, $523,500 and $349,000 for Messrs. Coleman, Stern, Lammas and Barton, respectively. The amounts reported in the Summary Compensation Table, and the amounts reported in this footnote
|
|
(4)
|
Mr. Vouvalides was promoted to Chief Investment Officer on February 20, 2014.
|
|
Name
|
|
Grant Date
|
|
Estimated Future Payouts Under Equity Incentive Plan Awards(1)
|
|
All Other Stock Awards: Number of Shares of Stock (#)
|
|
Grant Date Fair Value of Stock Awards ($)
|
|||||
|
|
|
|
|
Target ($)
|
|
Maximum ($)
|
|
|
|
|
|||
|
Victor J. Coleman
|
|
January 1, 2013
|
|
2,500,300
|
|
|
2,500,300
|
|
|
—
|
|
|
941,022 (2)
|
|
|
December 29, 2013
|
|
—
|
|
|
—
|
|
|
79,221 (3)
|
|
|
1,487,770 (4)
|
|
|
Howard S. Stern
|
|
January 1, 2013
|
|
1,650,000
|
|
|
1,650,000
|
|
|
—
|
|
|
621,000 (2)
|
|
Mark T. Lammas
|
|
January 1, 2013
|
|
1,650,000
|
|
|
1,650,000
|
|
|
—
|
|
|
621,000 (2)
|
|
|
December 29, 2013
|
|
—
|
|
|
—
|
|
|
40,742 (3)
|
|
|
765,135 (4)
|
|
|
Christopher Barton
|
|
January 1, 2013
|
|
1,100,000
|
|
|
1,100,000
|
|
|
—
|
|
|
414,000 (2)
|
|
|
December 29, 2013
|
|
—
|
|
|
—
|
|
|
14,713 (3)
|
|
|
276,310 (4)
|
|
|
Alexander Vouvalides
|
|
January 1, 2013
|
|
825,000
|
|
|
825,000
|
|
|
—
|
|
|
310,500 (2)
|
|
|
June 29, 2013
|
|
—
|
|
|
—
|
|
|
7,049 (5)
|
|
|
127,517 (4)
|
|
|
|
|
December 29, 2013
|
|
—
|
|
|
—
|
|
|
14,713 (3)
|
|
|
276,310 (4)
|
|
(1)
|
Amounts reflect awards granted under the 2013 OPP. The number of shares to be paid under these awards will equal the dollar value of the bonus pool divided by our per share common stock value at the time of payment. The dollar value of the bonus pool, in turn, will range from $0 to $11,000,000 depending on the Company’s absolute and relative TSR performance over the performance period. Amounts in the “Maximum” column represent the amounts the named executive officers will be eligible to receive if we achieve performance at a level sufficient to fund the 2013 OPP bonus pool at the maximum of $11,000,000. Amounts in the “Target” column represent the amounts the named executive officers would receive if our absolute and relative TSR performance for the performance period under the 2013 OPP continues at the same rate as we experienced from January 1, 2013, the first day of the performance period, through December 31, 2013. Awards under the 2013 OPP will be paid in the form of shares of common stock and RSUs (or, if the performance period terminates earlier upon a change in control, in the form of shares only). For additional information on the 2013 OPP, see “
Elements of Executive Officer Compensation-Outperformance Program
” above.
|
|
(2)
|
Amounts reflect the full grant date fair value of awards granted under the 2013 OPP determined in accordance with ASC Topic 718 based on the named executive officer’s percentage participation right in the 2013 OPP bonus pool. We provide information regarding the assumptions used to calculate the value of all awards under the 2013 OPP made to executive officers in Notes 2 and 10 to the consolidated financial statements contained in our Annual Report on Form 10-K, filed March 3, 2014. There can be no assurance that awards will vest (if an award does not vest, no value will be realized by the individual).
|
|
(3)
|
On December 29, 2013, our Compensation Committee approved restricted stock awards for each named executive officer, each of which will vest, and the restrictions thereon will lapse, in three equal, annual installments on each of December 29, 2014, December 29, 2015 and December 29, 2016, subject to continued service with us through the applicable vesting dates (and further subject to accelerated vesting upon a change in control or certain terminations as described below in the section entitled “Potential Payments Upon Termination or Change in Control”).
|
|
(4)
|
Amounts reflect the full grant date fair value of restricted stock granted during 2013 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all restricted stock awards made to executive officers in Notes 2 and 10 to the consolidated financial statements contained in our Annual Report on Form 10-K, filed March 3, 2014. There can be no assurance that awards will vest (if an award does not vest, no value will be realized by the individual).
|
|
(5)
|
On June 29, 2013, our Compensation Committee approved restricted stock awards for certain of our executive officers, each of which will vest, and the restrictions thereon will lapse, in three equal, annual installments on each of June 29, 2014, June 29, 2015 and June 29, 2016, subject to continued service with us through the applicable vesting dates (and further subject to accelerated vesting upon a change in control or certain terminations as described below in the section entitled “Potential Payments Upon Termination or Change in Control”).
|
|
|
|
Stock Awards
|
||||||||
|
Name
|
|
Number of Shares of Stock That Have Not Vested (#)
|
|
Market Value of Shares of Stock That Have Not Vested ($)
|
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)
|
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(1)
|
||
|
Victor J. Coleman
|
|
36,846 (2)
|
|
805,822 (3)
|
|
—
|
|
|
—
|
|
|
|
59,610 (4)
|
|
1,303,671 (3)
|
|
—
|
|
|
—
|
|
|
|
|
79,221 (5)
|
|
1,732,563 (3)
|
|
—
|
|
|
—
|
|
|
|
|
45,724 (6)
|
|
999,984 (7)
|
|
68,587 (8)
|
|
|
1,499,998
|
|
|
|
|
20,786 (9)
|
|
454,590 (10)
|
|
93,539 (11)
|
|
|
2,045,698
|
|
|
|
Howard S. Stern
|
|
16,580 (2)
|
|
362,605 (3)
|
|
—
|
|
|
—
|
|
|
|
24,116 (4)
|
|
528,510 (3)
|
|
—
|
|
|
—
|
|
|
|
|
27,434 (6)
|
|
599,982 (7)
|
|
41,152 (8)
|
|
|
899,994
|
|
|
|
|
13,717 (9)
|
|
299,991 (10)
|
|
61,728 (11)
|
|
|
1,349,991
|
|
|
|
Mark T. Lammas
|
|
10,439 (2)
|
|
228,301 (3)
|
|
—
|
|
|
—
|
|
|
|
24,166 (4)
|
|
528,510 (3)
|
|
—
|
|
|
—
|
|
|
|
|
40,742 (5)
|
|
891,028 (3)
|
|
—
|
|
|
—
|
|
|
|
|
27,434 (6)
|
|
599,982 (7)
|
|
41,152 (8)
|
|
|
899,994
|
|
|
|
|
13,717 (9)
|
|
299,991 (10)
|
|
61,728 (11)
|
|
|
1,349,991
|
|
|
|
Christopher Barton
|
|
6,141 (2)
|
|
134,304 (3)
|
|
—
|
|
|
—
|
|
|
|
10,472 (4)
|
|
229,023 (3)
|
|
—
|
|
|
—
|
|
|
|
|
14,713 (5)
|
|
321,773 (3)
|
|
—
|
|
|
—
|
|
|
|
|
18,289 (6)
|
|
399,980 (7)
|
|
27,434 (8)
|
|
|
599,982
|
|
|
|
|
9,144 (9)
|
|
199,979 (10)
|
|
41,152 (11)
|
|
|
899,994
|
|
|
|
Alexander Vouvalides
|
|
2,457 (2)
|
|
53,735 (3)
|
|
—
|
|
|
—
|
|
|
|
6,445(4)
|
|
140,952 (3)
|
|
—
|
|
|
—
|
|
|
|
|
14,713 (5)
|
|
321,773 (3)
|
|
—
|
|
|
—
|
|
|
|
|
7,049 (12)
|
|
154,162 (3)
|
|
|
|
|
—
|
|
|
|
|
9,144 (6)
|
|
199,979 (7)
|
|
13,717 (8)
|
|
|
299,991
|
|
|
|
|
|
6,858 (9)
|
|
149,984 (10)
|
|
30,864 (11)
|
|
|
674,996
|
|
|
(1)
|
The market value of unearned rights in the OPPs is calculated by multiplying the fair value of a share of our common stock on December 31, 2013 ($21.87) by the number of shares equivalent to the fair value of each named executive officer’s participation interest in the applicable OPP bonus pool (as determined in accordance with SEC rules and footnotes 8 and 11 below). For more information about the OPPs, see “Elements of Executive Officer Compensation-Outperformance Programs” above.
|
|
(2)
|
Consists of restricted stock granted on December 29, 2011, which vests in three substantially equal installments on each of December 29, 2012, 2013 and 2014, subject to continued service with us through the applicable vesting dates.
|
|
(3)
|
The market value of shares of restricted stock that have not vested is calculated by multiplying the fair market value of a share of our common stock on December 31, 2013 ($21.87) by the number of unvested shares of restricted stock outstanding under the award.
|
|
(4)
|
Consists of restricted stock granted on December 29, 2012, which vests in three substantially equal installments on each of December 29, 2013, 2014 and 2015, subject to continued service with us through the applicable vesting dates.
|
|
(5)
|
Consists of restricted stock granted on December 29, 2013, which vests in three substantially equal installments on each of December 29, 2014, 2015 and 2016, subject to continued service with us through the applicable vesting dates.
|
|
(6)
|
Consists of (i) 25%, 15%, 15%, 10% and 5% for Messrs. Coleman, Stern, Lammas, Barton and Vouvalides, respectively, multiplied by (ii) $4,000,000, which equals the minimum bonus pool established and earned under the 2012 OPP as of December 31, 2013, divided by (iii) $21.87, which is the fair market value of a share of our common stock on December 31, 2013. Any awards earned under the 2012 OPP upon the completion of the three-year performance period will be paid 50% in fully vested shares of our common stock and 50% in RSUs that vest in equal annual installments on December 31, 2015 and December 15, 2016, subject to continued employment. If the performance period ends prior to its three-year term upon a change in control, any awards earned will be paid only in shares.
|
|
(7)
|
The market value of earned rights in the 2012 OPP is calculated by multiplying the fair value of a share of our common stock on December 31, 2013 ($21.87) by the number of shares equivalent to the fair value of each named executive officer’s participation interest in the established minimum 2012 OPP bonus pool (as determined in accordance with SEC rules and footnote 6 above).
|
|
(8)
|
Consists of (i) 25%, 15%, 15%, 10% and 5% for Messrs. Coleman, Stern, Lammas, Barton and Vouvalides, respectively, multiplied by (ii) $6,000,000, which equals the remaining bonus pool that is eligible to be earned under the 2012 OPP assuming the Company’s absolute and relative TSR performance for the three-year performance period under the 2012 OPP continues at the same rate as we experienced from January 1, 2012, the first day of the performance period, through December 31, 2013, divided by (iii) $21.87, which is the fair market value of a share of our common stock on December 31, 2013. Any awards earned under the 2012 OPP upon the completion of the three-year performance period will be paid 50% in fully vested shares of our common stock and 50% in RSUs that vest in equal annual installments on December 31, 2015 and December 15, 2016, subject to continued employment. If the performance period ends prior to its three-year term upon a change in control, any awards earned will be paid only in shares.
|
|
(9)
|
Consists of (i) 22.73%, 15%, 15%, 10% and 7.5% for Messrs. Coleman, Stern, Lammas, Barton and Vouvalides, respectively, multiplied by (ii) $2,000,000, which equals the minimum bonus pool established and earned under the 2013 OPP as of December 31, 2013, divided by (iii) $21.87, which is the fair market value of a share of our common stock on December 31, 2013. Any awards earned under the 2013 OPP upon the completion of the three-year performance period will be paid 50% in fully vested shares of our common stock and 50% in RSUs that vest in equal annual installments on December 31, 2016 and December 15, 2017, subject to continued employment. If the performance period ends prior to its three-year term upon a change in control, any awards earned will be paid only in shares.
|
|
(10)
|
The market value of earned rights in the 2013 OPP is calculated by multiplying the fair value of a share of our common stock on December 31, 2013 ($21.87) by the number of shares equivalent to the fair value of each named executive officer’s participation interest in the established minimum 2013 OPP bonus pool (as determined in accordance with SEC rules and footnote 9 above).
|
|
(11)
|
Consists of (i) 22.73%, 15%, 15%, 10% and 7.5% for Messrs. Coleman, Stern, Lammas, Barton and Vouvalides, respectively, multiplied by (ii) $9,000,000, which equals the remaining bonus pool that is eligible to be earned under the 2013 OPP assuming the Company’s absolute and relative TSR performance for the three-year performance period under the 2013 OPP continues at the same rate as we experienced from January 1, 2013, the first day of the performance period, through December 31, 2013, divided by (iii) $21.87, which is the fair market value of a share of our common stock on December 31, 2013. Any awards earned under the 2013 OPP upon the completion of the three-year performance period will be paid 50% in fully vested shares of our common stock and 50% in RSUs that vest in equal annual installments on December 31, 2016 and December 15, 2017, subject to continued employment. If the performance period ends prior to its three-year term upon a change in control, any awards earned will be paid only in shares.
|
|
(12)
|
Consists of restricted stock granted on June 29, 2013, which vests in three substantially equal installments on each of June 29, 2014, 2015 and 2016, subject to continued service with us through the applicable vesting dates.
|
|
Name
|
|
Stock Awards
|
||||
|
|
|
Number of Shares Acquired on Vesting (#)
|
|
|
Value Realized on Vesting ($)
(1)
|
|
|
Victor J. Coleman
|
|
66,651
|
|
|
1,472,321
|
|
|
Howard S. Stern
|
|
28,664
|
|
|
633,188
|
|
|
Mark T. Lammas
|
|
22,523
|
|
|
497,533
|
|
|
Christopher Barton
|
|
11,377
|
|
|
251,318
|
|
|
Alexander Vouvalides
|
|
11,377
|
|
|
125,427
|
|
|
(1)
|
Amounts shown are calculated by multiplying the fair market value of our common stock on the applicable vesting date by the number of shares of restricted stock that vested on such date.
|
|
•
|
A lump-sum payment in an amount equal to two (or, with respect to Messrs. Coleman and Stern, three) times the sum of (i) the executive’s annual base salary then in effect, (ii) the highest annual bonus earned by the executive during the employment term and (iii) the highest value of any annual equity award(s) granted to the executive during the employment term (not including the initial grant of restricted stock described above or any award(s) granted pursuant to a multi-year or long-term performance program, initial hiring or retention award or similar non-reoccurring award);
|
|
•
|
Accelerated vesting of all outstanding equity awards held by the executive as of the termination date (other than any outperformance program awards, for which accelerated vesting provisions are described below); and
|
|
•
|
Company-subsidized continuation healthcare coverage for up to 18 months after the termination date.
|
|
Name
|
Benefit
|
|
Death($)
|
|
Disability($)
|
|
Termination Without Cause or for Good Reason (no Change in Control) ($)
|
|
Change in Control (no Termination) ($)
(1)
|
|
Termination Without Cause or for Good Reason in Connection with a Change in Control($)
(1)
|
|||||
|
Victor J. Coleman
|
Cash Severance
(2)
|
|
—
|
|
|
—
|
|
|
10,949,988
|
|
|
—
|
|
|
10,949,988
|
|
|
Continued Health Benefits
(3)
|
|
—
|
|
|
—
|
|
|
38,933
|
|
|
—
|
|
|
38,933
|
|
|
|
Equity Acceleration
|
|
8,842,356
(4)
|
|
|
8,842,356
(4)
|
|
|
6,342,156
(5)
|
|
|
5,171,775
(6)
|
|
|
$9,013,831
(7)
|
|
|
|
Life Insurance
(8)
|
|
50,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
8,892,356
|
|
|
8,842,356
|
|
|
17,331,077
|
|
|
5,171,775
|
|
|
20,002,752
|
|
|
|
Howard S. Stern
|
Cash Severance
(2)
|
|
—
|
|
|
—
|
|
|
5,324,976
|
|
|
—
|
|
|
5,324,976
|
|
|
Continued Health Benefits
(3)
|
|
—
|
|
|
—
|
|
|
38,933
|
|
|
—
|
|
|
38,933
|
|
|
|
Equity Acceleration
|
|
4,041,115
(4)
|
|
|
4,041,115
(4)
|
|
|
2,441,115
(5)
|
|
|
3,256,310
(6)
|
|
|
4,147,425
(7)
|
|
|
|
Life Insurance
(8)
|
|
50,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
4,091,115
|
|
|
4,041,115
|
|
|
7,805,024
|
|
|
3,256,310
|
|
|
9,511,334
|
|
|
|
Mark T. Lammas
|
Cash Severance
(2)
|
|
—
|
|
|
—
|
|
|
3,599,982
|
|
|
—
|
|
|
3,599,982
|
|
|
Continued Health Benefits
(3)
|
|
—
|
|
|
—
|
|
|
38,933
|
|
|
—
|
|
|
38,933
|
|
|
|
Equity Acceleration
|
|
4,797,839
(4)
|
|
|
4,797,839
(4)
|
|
|
3,197,839
(5)
|
|
|
3,256,310
(6)
|
|
|
4,904,194
(7)
|
|
|
|
Life Insurance
(8)
|
|
50,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
4,847,839
|
|
|
4,797,839
|
|
|
6,836,754
|
|
|
3,256,310
|
|
|
8,543,064
|
|
|
|
Christopher Barton
|
Cash Severance
(2)
|
|
—
|
|
|
—
|
|
|
2,200,020
|
|
|
—
|
|
|
2,200,020
|
|
|
Continued Health Benefits
(3)
|
|
—
|
|
|
—
|
|
|
38,933
|
|
|
—
|
|
|
38,933
|
|
|
|
Equity Acceleration
|
|
2,785,100
(4)
|
|
|
2,785,100
(4)
|
|
|
1,718,433
(5)
|
|
|
2,170,874
(6)
|
|
|
2,855,974
(7)
|
|
|
|
Life Insurance
(8)
|
|
50,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
2,835,100
|
|
|
2,785,100
|
|
|
3,957,386
|
|
|
2,170,874
|
|
|
5,094,927
|
|
|
|
Alexander Vouvalides
|
Cash Severance
(2)
|
|
—
|
|
|
—
|
|
|
2,020,020
|
|
|
—
|
|
|
2,020,020
|
|
|
Continued Health Benefits
(3)
|
|
—
|
|
|
—
|
|
|
38,933
|
|
|
—
|
|
|
38,933
|
|
|
|
Equity Acceleration
|
|
1,278,955
(4)
|
|
|
1,278,955
(4)
|
|
|
1,278,955
(5)
|
|
|
1,366,724
(6)
|
|
|
2,037,346
(7)
|
|
|
|
Life Insurance
(8)
|
|
50,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
1,328,955
|
|
|
1,278,955
|
|
|
3,337,908
|
|
|
1,366,724
|
|
|
4,096,299
|
|
|
|
(1)
|
In accordance with the employment agreement terms, if any payments made in connection with a change in control would otherwise be subject to an excise tax under Section 4999 of the Code by reason of the “golden parachute” rules contained in Section 280G of the
Code, such payments will be reduced if and to the extent that doing so will result in net after-tax payments and benefits for the executive officer that are more favorable than the net after-tax payments and benefits payable to the executive officer in the absence of such a reduction after the imposition of the excise tax. The figures reported in this column do not reflect any such reductions as a result of Code Section 280G limits. No executive officer is entitled to any tax gross-up payment in connection with change in control payments (or otherwise).
|
|
(2)
|
Cash severance was calculated by multiplying the applicable severance multiple (described above) by the sum of (i) the executive officer’s annual base salary in effect on December 31, 2013; (ii) the highest annual bonus earned by the executive officer during the employment term; and (iii) the highest value of any annual equity award made to the executive officer during the employment term, not including any initial grant of restricted stock awarded in connection with the employment agreement or any outperformance program awards granted to the executive officer.
|
|
(3)
|
Represents the aggregate premium payments that we would be required to pay to or on behalf of the applicable executive to provide continued health insurance coverage under COBRA (based on the executive’s health insurance coverage elections as of December 31, 2013) for 18 months.
|
|
(4)
|
Represents, for each executive officer, the sum of the values attributable to (i) the accelerated vesting of the unvested portion of all outstanding shares of restricted stock held by the executive officer as of December 31, 2013, plus (ii) the accelerated vesting of the 2012 OPP and 2013 OPP award held by the executive officer. Amounts do not include the dividend equivalents that may become payable in respect of the executive’s 2012 OPP and 2013 OPP award upon the termination, as that amount is not yet determinable. As required by applicable disclosure rules, these values reflect a hypothetical termination of the executive’s employment occurring on December 31, 2013.
|
|
Name
|
|
December 2011 Grant
|
|
December 2012 Grant
|
|
June 2013 Grant
|
|
December 2013 Grant
|
|
Mr. Coleman
|
|
36,846 shares
|
|
59,610 shares
|
|
0 shares
|
|
79,221 shares
|
|
Mr. Stern
|
|
16,580 shares
|
|
24,166 shares
|
|
0 shares
|
|
0 shares
|
|
Mr. Lammas
|
|
10,439 shares
|
|
24,166 shares
|
|
0 shares
|
|
40,742 shares
|
|
Mr. Barton
|
|
6,141 shares
|
|
10,472 shares
|
|
0 shares
|
|
14,713 shares
|
|
Mr. Vouvalides
|
|
2,457 shares
|
|
6,445 shares
|
|
7,049 shares
|
|
14,713 shares
|
|
(5)
|
Represents, for each executive officer, the sum of the values attributable to (i) the accelerated vesting of the unvested portion of all outstanding shares of restricted stock held by the executive officer as of December 31, 2013, plus (ii) the pro-rated accelerated vesting of the 2012 OPP award and 2013 OPP award held by the executive officer. Amounts do not include the dividend equivalents that may become payable in respect of the executive’s 2012 OPP award and 2013 OPP award upon the termination, as that amount is not yet determinable. As required by applicable disclosure rules, these values reflect a hypothetical termination of the executive’s employment occurring on December 31, 2013.
|
|
Name
|
|
December 2011 Grant
|
|
December 2012 Grant
|
|
June 2013 Grant
|
|
December 2013 Grant
|
|
Mr. Coleman
|
|
36,846 shares
|
|
59,610 shares
|
|
0 shares
|
|
79,221 shares
|
|
Mr. Stern
|
|
16,580 shares
|
|
24,166 shares
|
|
0 shares
|
|
0 shares
|
|
Mr. Lammas
|
|
10,439 shares
|
|
24,166 shares
|
|
0 shares
|
|
40,742 shares
|
|
Mr. Barton
|
|
6,141 shares
|
|
10,472 shares
|
|
0 shares
|
|
14,713 shares
|
|
Mr. Vouvalides
|
|
2,457 shares
|
|
6,445 shares
|
|
7,049 shares
|
|
14,713 shares
|
|
(6)
|
Represents, for each executive officer, the full accelerated vesting of the 2012 OPP award and 2013 OPP award held by the executive officer based on actual performance through December 31, 2013, plus the dividend equivalents that would become payable in respect of the executive’s 2012 OPP and 2013 OPP awards upon the change in control. As required by applicable disclosure rules, these values reflect a hypothetical change in control occurring on December 31, 2013.
|
|
(7)
|
Represents, for each executive officer, the sum of the values attributable to (i) the accelerated vesting of the unvested portion of all outstanding shares of restricted stock held by the executive officer as of December 31, 2013, plus (ii) the full accelerated vesting of the 2012 OPP award and 2013 OPP award held by the executive officer based on actual performance through December 31, 2013. As required by applicable disclosure rules, these values reflect a hypothetical change in control and qualifying termination of the executive’s employment occurring on December 31, 2013.
|
|
Name
|
|
December 2011 Grant
|
|
December 2012 Grant
|
|
June 2013 Grant
|
|
December 2013 Grant
|
|
Mr. Coleman
|
|
36,846 shares
|
|
59,610 shares
|
|
0 shares
|
|
79,221 shares
|
|
Mr. Stern
|
|
16,580 shares
|
|
24,166 shares
|
|
0 shares
|
|
0 shares
|
|
Mr. Lammas
|
|
10,439 shares
|
|
24,166 shares
|
|
0 shares
|
|
40,742 shares
|
|
Mr. Barton
|
|
6,141 shares
|
|
10,472 shares
|
|
0 shares
|
|
14,713 shares
|
|
Mr. Vouvalides
|
|
2,457 shares
|
|
6,445 shares
|
|
7,049 shares
|
|
14,713 shares
|
|
(8)
|
Represents the life insurance proceeds payable by a third-party insurer under the executive’s life insurance policy upon a termination of employment due to death.
|
|
Plan Category
|
|
Number of Securities
to be Issued Upon
Exercise of
Outstanding Options, Warrants and Rights
|
|
Weighted Average
Exercise Price of
Outstanding Options
|
|
Number of Securities
Remaining
Available
for Future Issuance
Under Equity
Compensation
Plans
(1)
|
||
|
Equity compensation plans approved by
stockholders
(2)
|
|
1,230,857
|
|
|
—
|
|
14,382,173
|
|
|
Equity compensation plans not approved by
stockholders
|
|
—
|
|
|
—
|
|
—
|
|
|
Total
|
|
1,230,857
|
|
|
—
|
|
14,382,173
|
|
|
(1)
|
Consists of the 2010 Plan.
|
|
(2)
|
As of December 31, 2013, 11,218,095 fungible units remained available for issuance under our 2010 Plan. This fungible unit limit means that, based on the relative fungible unit weights attributable to different award types under the plan, the maximum number of shares that may be issued under the plan as of December 31, 2013 ranged from 3,802,744 to 14,382,173 shares, with the ultimate share limit determined by reference to the types of awards actually granted under the plan. The amount disclosed in the table represents the number of shares that would be available for issuance if all awards made after December 31, 2013 are granted as five-year options.
|
|
•
|
We evaluate performance based on a variety of business objectives, including but not limited to, execution of capital markets strategy, expansion of asset base, sourcing and completion of accretive acquisitions, strength of balance sheet, earnings, and occupancy and leasing performance, that we believe correlate to the long-term, sustainable creation of stockholder value;
|
|
•
|
The most material component of equity-based executive compensation since completion of our IPO has been in the form of restricted stock and our outperformance programs, which pays out in common stock and restricted stock units, each of which, as compared to stock options or other market-based equity compensation vehicles, retains some degree of value even in periods of depressed markets and thus provides executives with a baseline of value that lessens the likelihood that executives will undertake any unnecessary risks to get or keep options (or other similar vehicle) “in-the-money”;
|
|
•
|
In 2013, our Compensation Committee retained ultimate discretion in setting compensation and did not rely on pre-determined formulas, therefore our executives were not encouraged to take unreasonable risks to meet certain hurdles to avoid not achieving the required formulaic metric; and
|
|
•
|
As the most material portion of each executive’s compensation to date has been in the form of stock, our executives have sizable holdings of equity in the Company, which aligns an appropriate portion of their personal wealth with our long-term performance. None of the shares of our stock or the common units of limited partnership interest in our operating partnership, or common units, owned by our directors and executive officers are pledged as collateral for a loan.
|
|
Name of Beneficial Owner
|
|
Number of Shares and Common Units Beneficially Owned
|
|
Percentage of Outstanding Common Stock
(1)
|
|
Percentage of Outstanding Common Stock and Common Units
(2)
|
|
|
Farallon Partners, L.L.C.
(3)
|
|
10,535,534
|
|
|
15.7%
|
|
15.2%
|
|
Invesco Ltd.
(4)
|
|
6,806,403
|
|
|
10.2%
|
|
9.8%
|
|
The Vanguard Group
(5)
|
|
5,881,350
|
|
|
8.8%
|
|
8.5%
|
|
Cohen & Steers, Inc.
(6)
|
|
4,810,530
|
|
|
7.2%
|
|
6.9%
|
|
Victor J. Coleman
(7)
|
|
989,526
|
|
|
1.5%
|
|
1.4%
|
|
Mark T. Lammas
|
|
126,841
|
|
|
*
|
|
*
|
|
Christopher Barton
|
|
63,936
|
|
|
*
|
|
*
|
|
Dale Shimoda
|
|
62,164
|
|
|
*
|
|
*
|
|
Alexander Vouvalides
|
|
35,594
|
|
|
*
|
|
*
|
|
Theodore R. Antenucci
|
|
17,059
|
|
|
*
|
|
*
|
|
Richard B. Fried
(8)
|
|
10,546,711
|
|
|
15.7%
|
|
15.2%
|
|
Jonathan M. Glaser
|
|
99,825
|
|
|
*
|
|
*
|
|
Mark D. Linehan
|
|
27,059
|
|
|
*
|
|
*
|
|
Robert M. Moran, Jr.
|
|
17,059
|
|
|
*
|
|
*
|
|
Barry A. Porter
|
|
49,575
|
|
|
*
|
|
*
|
|
Patrick Whitesell
|
|
8,502
|
|
|
*
|
|
*
|
|
All directors and executive officers as a group (15 persons)
|
|
12,114,366
|
|
|
18.1%
|
|
17.5%
|
|
(1)
|
Based on 67,027,472 shares of common stock outstanding as of March 25, 2014. In addition, amounts for each person assume that all common units held by the person are exchanged for shares of our common stock, and amounts for all directors and executive officers as a group assume all common units held by them are exchanged for shares of our common stock, in each case, regardless of when such common units are exchangeable. The total number of shares of our common stock outstanding used in calculating this percentage assumes that none of the common units held by other persons are exchanged for shares of our common stock.
|
|
(2)
|
Based on 67,027,472 shares of common stock outstanding as of March 25,2014 and 2,382,563 outstanding common units held by limited partners as of March 25, 2013, which units may be redeemed for cash or, at our option, exchanged for shares of our common stock. Does not include shares of our common stock that may be issued upon exchange of our series A preferred units issued of limited partnership interest in our operating partnership in the formation transactions or upon exchange of common units into which such series A preferred units may be converted.
|
|
(3)
|
Farallon Partners, L.L.C., a Delaware limited liability company, or FPLLC, is the general partner of each of Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P. and Farallon Capital Institutional Partners III, L.P., referred to collectively as the Farallon Funds, and as such may be deemed to beneficially own the shares of our common stock or the common units in our operating partnership held by each of the Farallon Funds. As managing members of FPLLC with the power to exercise investment discretion, each of Richard B. Fried, Daniel J. Hirsch, David T. Kim, Monica R. Landry, Michael G. Linn, Rajiv A. Patel, Thomas G. Roberts, Jr., Andrew J. M. Spokes, John R. Warren and Mark C. Wehrly, referred to collectively as the Farallon Managing Members, may be deemed to beneficially own the shares of our common stock or the common units in our operating partnership held by each of the Farallon Funds. Each of FPLLC and the Farallon Managing Members disclaims beneficial ownership of the shares of our common stock and the common units in our operating partnership held by the Farallon Funds. All of the entities and individuals identified in this footnote disclaim group attribution. Richard B. Fried, a Farallon Managing Member, is a member of our Board of Directors. The address for all of the above mentioned entities and persons is One Maritime Plaza, Suite 2100, San Francisco, CA 94111. The information in this footnote is based solely upon information provided in our prospectus supplement filed on March 21, 2014.
|
|
(4)
|
Invesco Ltd., a Bermuda corporation, is the parent of Invesco Advisers, Inc. and Invesco PowerShares Capital Management, each an investment adviser, and Invesco Ltd. may be deemed to beneficially own the shares held by these investment advisers. The information in this footnote is based solely upon a Schedule 13G/A filed on February 12, 2014.
|
|
(5)
|
The Vanguard Group, a Pennsylvania corporation, is the parent holding company of Vanguard Fiduciary Trust Company, a Delaware limited liability company, and Vanguard Investments Australia, Ltd. The Vanguard Group, Inc. may be deemed to beneficially own the shares owned by Vanguard Fiduciary Trust Company and Vanguard Investments Australia, Ltd. The principal address for The Vanguard Group, Inc. is 100 Vanguard Blvd., Malvern, PA, 19355. The information in this footnote is based solely upon a Schedule 13G/A filed by The Vanguard Group on February 11, 2014.
|
|
(6)
|
Cohen & Steers, Inc., a Delaware corporation, holds a 100% interest in Cohen & Steers Capital Management, Inc., an investment advisor and a New York corporation. Cohen & Steers, Inc. may be deemed to beneficially own the shares owned by Cohen & Steers Capital Management, Inc. The principal address for Cohen & Steers, Inc. and Cohen & Steers Capital Management, Inc. is 280 Park Avenue, 10
th
Floor, New York, NY 10017. The information in this footnote is based solely upon a Schedule 13G/A filed by Cohen & Steers, Inc. on February 14, 2014.
|
|
(7)
|
Includes shares of common stock held by the 2012 Coleman Gift Trust, over which Victor Coleman exercises investment control. The beneficiaries of the 2012 Coleman Gift Trust are Mr. Coleman’s children.
|
|
(8)
|
Includes shares of common stock and common units held by the Farallon Funds and shares of restricted stock held individually by Richard B. Fried. Mr. Fried is a managing member (with the power to exercise investment discretion) of Farallon Partners, L.L.C., the general partner of each of the Farallon Funds and as such may be deemed to have beneficial ownership of the shares of common stock and common units owned by the Farallon Funds. Mr. Fried disclaims beneficial ownership of all such shares and common units held by the Farallon Funds. The information in this footnote is based solely upon information provided in our prospectus supplement filed on March 21, 2014.
|
|
•
|
the amounts involved exceeded or will exceed $120,000; and
|
|
•
|
any of our directors, executive officers, holders of more than 5% of our common stock or any member of their immediate family had or will have a direct or indirect material interest.
|
|
|
|
|
|
|
|
|
|
|
•
|
a written affirmation of the indemnitee’s good faith belief that he or she has met the standard of conduct necessary for indemnification; and
|
|
•
|
a written unsecured undertaking to reimburse us if a court of competent jurisdiction determines that the director or executive officer is not entitled to indemnification.
|
|
•
|
our directors, nominees for director or executive officers;
|
|
•
|
any beneficial owner of more than 5% of any class of our voting securities;
|
|
•
|
any immediate family member of any of the foregoing persons; and
|
|
•
|
any entity in which any of the foregoing persons has a substantial ownership interest or control of such entity.
|
|
By Order of the Board of Directors
|
|
|
Kay L. Tidwell
|
|
Executive Vice President, General Counsel and Secretary
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|